Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial

Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial

BackgroundThis is a subgroup analysis of Korean patients from a phase 3 clinical trial investigating the efficacy and safety of ipragliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin.MethodsThis multicenter, placebo-controlled, double-blind, parallel-group stu...

Full description

Bibliographic Details
Main Authors: Kyung-Wan Min, Bon Jeong Ku, Ji-Hyun Lee, Min-Seon Kim, Kyu-Jeung Ahn, Moon-Kyu Lee, Satoshi Kokubo, Satoshi Yoshida, Hyun-Ji Cho, Bong-Soo Cha
Format: Article
Language:English
Published: Korean Diabetes Association 2017-01-01
Series:Diabetes & Metabolism Journal
Subjects:
Asia
Diabetes mellitus, type 2
Ipragliflozin
Korea
Metformin
Randomized controlled trial
Sodium-glucose cotransporter 2 inhibitor
Online Access:https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-41-135.pdf

Internet

https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-41-135.pdf

Similar Items